| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MPA.0B013E3182962ACB |
| P698 | PubMed publication ID | 24048456 |
| P2093 | author name string | Hui Chen | |
| Zhaoshen Li | |||
| Jun Gao | |||
| Hongyu Wu | |||
| Xiangyu Kong | |||
| Yiqi Du | |||
| Jianqiang Liu | |||
| Minghao Liu | |||
| Yanfang Gong | |||
| P433 | issue | 7 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 1169-1181 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells | |
| P478 | volume | 42 |
| Q24563998 | Advances in pancreatic cancer research: moving towards early detection |
| Q52595056 | Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes. |
| Q37150545 | Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion |
| Q38670577 | Current and future biomarkers for pancreatic adenocarcinoma |
| Q38645087 | Downregulation of microRNA-196a inhibits human liver cancer cell proliferation and invasion by targeting FOXO1. |
| Q33561359 | Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively |
| Q38547009 | Evaluation of small noncoding RNAs in ex vivo stored human mature red blood cells: changes in noncoding RNA levels correlate with storage lesion events |
| Q35599241 | ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53 |
| Q58792092 | ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid |
| Q52789821 | Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis. |
| Q26859017 | Keep-ING balance: tumor suppression by epigenetic regulation |
| Q26749037 | Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy |
| Q37584834 | MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression |
| Q90312107 | MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential |
| Q38850617 | MicroRNA in pancreatic cancer |
| Q26769953 | MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions |
| Q38867232 | MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. |
| Q36249508 | Molecular Imaging with MRI: Potential Application in Pancreatic Cancer |
| Q35815485 | New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer |
| Q89148846 | Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application |
| Q35651346 | Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes |
| Q49793590 | Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression |
| Q90022490 | The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer |
| Q38983618 | The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis |
| Q41345808 | The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy |
| Q64901256 | miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1. |
| Q61805831 | microRNA-196a attenuates ischemic brain injury in rats by directly targeting high mobility group A1 |
Search more.